126 related articles for article (PubMed ID: 38373302)
21. Presurgical predictive factors of surgical remission in Cushing's disease. Study of 32 cases.
Araujo-Castro M; Marchán Pinedo M; Fernández-Argüeso M; Pérez Pérez M; Barrero Ruíz E; Pian H; Rodríguez Berrocal V; Pascual-Corrales E
Endocrinol Diabetes Nutr (Engl Ed); 2022 Oct; 69(8):584-590. PubMed ID: 36446484
[TBL] [Abstract][Full Text] [Related]
22. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
23. Urinary free cortisol in the diagnosis of Cushing's syndrome: how useful?
Odeniyi IA; Fasanmade OA
Niger J Clin Pract; 2013; 16(3):269-72. PubMed ID: 23771444
[TBL] [Abstract][Full Text] [Related]
24. Cushing's Syndrome: Screening and Diagnosis.
Ceccato F; Boscaro M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
[TBL] [Abstract][Full Text] [Related]
25. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
26. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
Klose M; Jørgensen K; Kristensen LØ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R; Fleseriu M; Newell-Price J; Bertagna X; Findling J; Shimatsu A; Gu F; Auchus R; Leelawattana R; Lee EJ; Kim JH; Lacroix A; Laplanche A; O'Connell P; Tauchmanova L; Pedroncelli AM; Biller BMK;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):748-761. PubMed ID: 32730798
[TBL] [Abstract][Full Text] [Related]
30. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
31. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
32. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
Kuzu I; Zuhur SS; Demir N; Aktas G; Yener Ozturk F; Altuntas Y
Endokrynol Pol; 2016; 67(5):487-492. PubMed ID: 26884297
[TBL] [Abstract][Full Text] [Related]
34. The recovery time of hypothalamic-pituitary-adrenal axis after curative surgery in Cushing's disease and its related factor.
Cui Q; Liu X; Sun Q; Sun W; Zheng H; He M; Zhang Z; Ma Z; Shen M; Shou X; Zhao Y; Li Y; Wang Y; Ye H; Zhang S
Endocrine; 2023 Aug; 81(2):349-356. PubMed ID: 37284972
[TBL] [Abstract][Full Text] [Related]
35. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
[TBL] [Abstract][Full Text] [Related]
36. Cushing's Disease as a Result of Two ACTH-Secreting Pituitary Tumors.
Mathai C; Anolik J
AACE Clin Case Rep; 2021; 7(2):149-152. PubMed ID: 34095475
[TBL] [Abstract][Full Text] [Related]
37. Increased Risk of Ocular Hypertension in Patients With Cushing's Disease.
Ma Y; Chen Z; Ma Z; Ye H; Zhang Z; Wang Y; Yang H; Lu Z; Wang Z; Qiao N; Xiao Y; Zhao Y
J Glaucoma; 2022 Dec; 31(12):941-946. PubMed ID: 35980841
[TBL] [Abstract][Full Text] [Related]
38. Remission in Cushing's disease is predicted by cortisol burden and its withdrawal following pituitary surgery.
Dutta A; Gupta N; Walia R; Bhansali A; Dutta P; Bhadada SK; Pivonello R; Ahuja CK; Dhandapani S; Hajela A; Simeoli C; Sachdeva N; Saikia UN
J Endocrinol Invest; 2021 Sep; 44(9):1869-1878. PubMed ID: 33453019
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up and predictors of recurrence of Cushing's disease.
Guignat L; Bertherat J
J Neuroendocrinol; 2022 Aug; 34(8):e13186. PubMed ID: 35979714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
